TITLE

Uremic Frost

AUTHOR(S)
Bhattarai, Nimesh; Panda, Mukta
PUB. DATE
December 2008
SOURCE
Mayo Clinic Proceedings;Dec2008, Vol. 83 Issue 12, p1309
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information on the causes and symptoms of uremic frost, an uncommon dermatologic manifestation of profound azotemia. According to the article, the dermatological manifestation of serious azotemia is rarely seen due to early dialysis intervention. It is stated that the concentration of urea in sweat increases largely when the blood urea nitrogen level is high. Moreover, evaporation of sweat with high urea concentration causes urea to crystallize and deposit on the skin.
ACCESSION #
35948732

 

Related Articles

  • Notes of a uremia watcher: Therapeutic technologies in uremia. Burton, Benjamin T. // Kidney International;Feb1975, Vol. 7 Issue 2, pS-267 

    The article focuses on the molecular toxicity of uremia and its modern therapeutic technologies as a topic of a symposium prepared by Physician George E. Schreiner. He said that if one wants to learn about the general practice of medicine, one can take care of a dialysis patient since it has all...

  • Provision of services to patients with chronic uremia. Kerr, D. N. S. // Kidney International;Jan1973, Vol. 3 Issue 1, p197 

    Presents the author's comments on health care services available for patients suffering from chronic uremia. Treatments available for chronic uremia patients in the U.S.; Expansion of hospital dialysis facilities in Great Britain; Information on the transplantation program launched in Great Britain.

  • Dialysis of the future. Gotch, Frank A. // Kidney International Supplement;Mar1988, Issue 24, pS-100 

    Discusses the possible development of the dialysis. Efforts to define an adequate dialysis prescription and understanding of the pathogenesis of the clinical uremic syndrome; Requirements of the dialyzer urea transport; Determination of the cell mass transfer coefficients.

  • Factors in the dialysis regimen which contribute to alterations in the abnormalities of uremia. Lowrie, Edmund G.; Steinberg, Steven M.; Galen, Malcolm A.; Gagneux, Stephan A.; Lazarus, J. Michael; Gottlieb, Michael N.; Merrill, John P. // Kidney International;Nov1976, Vol. 10 Issue 5, p409 

    While hemodialysis therapy in its present form is capable of sustaining life, dialysis patients are not metabolically normal and we are unable to say what technical factors contribute adequate therapy. Recent efforts to resolve these problems have led to the assumption that substances in the...

  • Chromogranin A in uremia: Progressive retention of immunoreactive fragments. Hsiao, Ray J.; Mezger, Matthew S.; O'Connor, Daniel T. // Kidney International;Mar1990, Vol. 37 Issue 3, p955 

    Chromogranin A is a soluble protein that is stored and released with catecholamines from their secretory vesicles, its measurement is a probe of exocytotic sympathoadrenal activity, and in plasma it may also be a useful tool in the diagnosis of peptide producing endocrine neoplasms. Because we...

  • Role of Nrf2 Dysfunction in Uremia-Associated Intestinal Inflammation and Epithelial Barrier Disruption. Lau, Wei; Liu, Shu-Man; Pahlevan, Sogol; Yuan, Jun; Khazaeli, Mahyar; Ni, Zhenmin; Chan, Jefferson; Vaziri, Nosratola // Digestive Diseases & Sciences;May2015, Vol. 60 Issue 5, p1215 

    Background: Gut inflammation is prevalent in chronic kidney disease (CKD) and likely contributes to systemic inflammation via disruption of the epithelial tight junction with subsequent endotoxin and bacterial translocation. Aims: To study the expression profile of inflammatory and tight...

  • Brain water and electrolyte metabolism in uremia: Effects of slow and rapid hemodialysis. Arieff, Allen I.; Massry, Shaul G.; Barrientos, Alberto; Kleeman, Charles R. // Kidney International;Sep1973, Vol. 4 Issue 3, p177 

    To evaluate the mechanism(s) of dialysis disequilibrium syndrome, measurements of pH and PCO2 in cerebrospinal fluid (CSF) and plasma, and of sodium, potassium, calcium, urea, creatinine, water content and osmolality in brain, CSF, and plasma were made in seven groups of dogs, including normal...

  • Effects of oxygen breathing and erythropoietin on hypoxic vasodilation in uremic anemia. Roger, Simon D.; Grasty, Marianne S.; Baker, Laurence R. I.; Raine, Anthony E. G. // Kidney International;Oct1992, Vol. 42 Issue 4, p975 

    Loss of hypoxic vasodilation has been proposed as a causative factor in the development of hypertension in dialysis patients treated with recombinant human erythropoietin (rHuHPO). Venous occlusion plethysmography was therefore performed on 22 dialysis patients (aged 23 to 71 years, dialysis...

  • Advanced oxidation protein products as a novel marker of oxidative stress in uremia. VÉronique Witko-Sarsat; Friedlander, Miriam; Capeillére-Blandin, Chantal; Nguyen-khoa, Thao; Nguyen, Anh Thu; Zingraff, Johanna; Jungers, Paul; Descamps-Latscha, Beatrice // Kidney International;May1996, Vol. 49 Issue 5, p1304 

    Evidence suggests an imbalance between antioxidant and oxidant-generating systems resulting in oxidative stress in uremic patients. As plasma proteins are critical targets for oxidants, we developed a novel spectrophotometric assay which allows to detect advanced oxidation protein products...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics